Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VKTX
#1285
Viking Therapeutics, Inc
33.8
4
+6.28%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+6.28%
Monthly Change
+7.46%
6 month change
+25.94%
Year Change
+20.43%
Previous Close
31.8
4
Open
33.8
4
Bid
Ask
Low
33.8
4
High
33.8
4
Volume
112
Markets
US Stock Market
Healthcare
VKTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?
Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026
American Express, Oracle among market cap stock movers on Monday
Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? (GPCR)
Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition?
Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk
NVO Crashes 21% in a Month: Is This an Indication to Sell the Stock?
Viking Therapeutics: Full-Speed Ahead (NASDAQ:VKTX)
Viking: Buyers Quietly Accumulating On Obesity Drugs Launch Potential (NASDAQ:VKTX)
Cisco and Micron among market cap stock movers on Thursday
How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report